foxo4 dri peptide FOXO4-DRI foxo4-dri peptide human clinical trial

various eye and vision abnormalities such as decreased blink rate, dry eyes, deficient ocular pursuit (eye tracking) and saccadic movements (fast automatic movements of both eyes in the same direction), difficulties in directing gaze upward, and blurred or double vision

Leavitt, M

Pickart holdS the patent on GHK and 2nd generation copper peptides

As a result, the disparity between safety profiles for GHK-Cu injection vs topical delivery methods is considerable

Some small-scale studies have suggested potential benefits in hair regrowth, but no adequately powered, placebo-controlled head-to-head trial has demonstrated that copper peptides perform comparably to 5% minoxidil